Use of prolactin receptor antagonist to better understand prolactin regulation of pituitary homeostasis

Neuroendocrinology

Volumn 98, Issue 3, 2013, Pages 171-179

  Ferraris, Jimena ^a   Bernichtein, Sophie ^b   Pisera, Daniel ^a   Goffin, Vincent ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Apoptosis; Del1 9 G129R hPRL; Pituitary; Prolactin; Prolactin receptor antagonist; Proliferation

Indexed keywords

DEL1 9 G129R HPRL; HORMONE RECEPTOR BLOCKING AGENT; PROLACTIN RECEPTOR; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; HOMEOSTASIS; HUMAN; HYPOPHYSIS; HYPOPHYSIS CELL; HYPOTHALAMUS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; HOMEOSTASIS; HUMANS; PITUITARY GLAND; PROLACTIN; PROTEIN BINDING; RECEPTORS, PROLACTIN; SIGNAL TRANSDUCTION;

EID: 84898436006     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000354701     Document Type: Article

References (92)

1. Stricker P, Greeter R: Action du lobe anterieur de l'hypophyse sur la montee laiteuse. C R Soc Biol 1928; 99: 1978-1980.
2. Riddle O, Bates RW, Dykshorn SW: The preparation, identification and assay of prolactin - a hormone of the anterior pituitary. Am J Physiol 1933; 105: 191-216.
3. Freeman ME, Kanyicska B, Lerant A, Nagy G: Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000; 80: 1523-1631.
4. Gillam MP, Molitch ME, Lombardi G, Colao A: Advances in the treatment of prolactinomas. Endocr Rev 2006; 27: 485-534. (Pubitemid 44213229)
5. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW: Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 1996; 17: 639-669. (Pubitemid 26425260)
6. Goffin V, Bernichtein S, Touraine P, Kelly PA: Development and potential clinical uses of human prolactin receptor antagonists. Endocr Rev 2005; 26: 400-422. (Pubitemid 40686651)
7. Goffin V, Hoang DT, Bogorad RL, Nevalainen MT: Prolactin regulation of the prostate gland: a female player in a male game. Nat Rev Urol 2011; 8: 597-607.
8. Brockman JL, Schroeder MD, Schuler LA: PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. Mol Endocrinol 2002; 16:774-784. (Pubitemid 34297746)
9. Shiu RP, Elsholtz HP, Tanaka T, Friesen HG, Gout PW, Beer CT, Noble RL: Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line. Endocrinology 1983; 113:159-165. (Pubitemid 13045132)
10. Nevalainen MT, Valve EM, Ingleton PM, Nurmi M, Martikainen PM, Harkonen PL: Prolactin and prolactin receptors are expressed and functioning in human prostate. J Clin Invest 1997; 99: 618-627. (Pubitemid 27097662)
11. Boutin JM, Jolicoeur C, Okamura H, Gagnon J, Edery M, Shirota M, Banville D, Dusanter-Fourt I, Djiane J, Kelly PA: Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell 1988; 53: 69-77.
12. Broutin I, Jomain JB, Tallet E, van Agthoven J, Raynal B, Hoos S, Kragelund BB, Kelly PA, Ducruix A, England P, Goffin V: Crystal structure of an affinity-matured prolactin complexed to its dimerized receptor reveals the topology of hormone binding site 2. J Biol Chem 2010; 285: 8422-8433.
13. Kopchick JJ, Parkinson C, Stevens EC, Trainer PJ: Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocr Rev 2002; 23: 623-646. (Pubitemid 35191626)
14. Goffin V, Tallet E, Jomain JB, Kelly PA: Development of prolactin receptor antagonists: same goal, different ways. Rec Pat Endocr Metab Imm Drug Disc 2007; 1: 41-52.
15. Bernichtein S, Kayser C, Dillner K, Moulin S, Kopchick JJ, Martial JA, Norstedt G, Isaksson O, Kelly PA, Goffin V: Development of pure prolactin receptor antagonists. J Biol Chem 2003; 278: 35988-35999. (Pubitemid 37139917)
16. Dagvadorj A, Collins S, Jomain JB, Abdulghani J, Karras J, Zellweger T, Li H, Nurmi M, Alanen K, Mirtti T, Visakorpi T, Bubendorf L, Goffin V, Nevalainen MT: Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway. Endocrinology 2007; 148: 3089-3101. (Pubitemid 46996970)
17. Eyal O, Jomain JB, Kessler C, Goffin V, Handwerger S: Autocrine prolactin inhibits human uterine decidualization: a novel role for prolactin.Biol Reprod 2007; 76: 777-783. (Pubitemid 46651218)
18. Hou L, Xu B, Mohankumar KM, Goffin V, Perry JK, Lobie PE, Liu DX: The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells. Int J Oncol 2012; 41: 2285-2295.
19. Pathipati P, Gorba T, Scheepens A, Goffin V, Sun Y, Fraser M: Growth hormone and prolactin regulate human neural stem cell regenerative activity. Neuroscience 2011; 190: 409-427.
20. Scotland PE, Patil M, Belugin S, Henry MA, Goffin V, Hargreaves KM, Akopian AN: Endogenous prolactin generated during peripheral inflammation contributes to thermal hyperalgesia. Eur J Neurosci 2011; 34: 745-754.
21. Ramot Y, Biro T, Tiede S, Toth BI, Langan EA, Sugawara K, Foitzik K, Ingber A, Goffin V, Langbein L, Paus R: Prolactin - a novel neuroendocrine regulator of human keratin expression in situ. FASEB J 2010; 24: 1768-1779.
22. Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N, Kelly PA: Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 1997; 11: 167-178. (Pubitemid 27081894)
23. Rouet V, Bogorad RL, Kayser C, Kessal K, Genestie C, Bardier A, Grattan DR, Kelder B, Kopchick JJ, Kelly PA, Goffin V: Local prolactin is a target to prevent expansion of basal/ stem cells in prostate tumors. Proc Natl Acad Sci USA 2010; 107: 15199-15204.
24. Goffin V, Touraine P, Culler MD, Kelly PA: Drug insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia? Nat Clin Pract Endocrinol Metab 2006; 2: 571-581. (Pubitemid 44536605)
25. Shingo T, Gregg C, Enwere E, Fujikawa H, Hassam R, Geary C, Cross JC, Weiss S: Pregnancy- stimulated neurogenesis in the adult female forebrain mediated by prolactin. Science 2003; 299: 117-120. (Pubitemid 36042416)
26. Larsen CM, Grattan DR: Prolactin, neurogenesis, and maternal behaviors. Brain Behav Immun 2012; 26: 201-209.
27. Sonigo C, Bouilly J, Carre N, Tolle V, Caraty A, Tello J, Simony-Conesa FJ, Millar R, Young J, Binart N: Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. J Clin Invest 2012; 122: 3791-3795.
28. Larsen CM, Grattan DR: Prolactin-induced mitogenesis in the subventricular zone of the maternal brain during early pregnancy is essential for normal postpartum behavioral responses in the mother. Endocrinology 2010; 151: 3805-3814.
29. Hirai J, Nishita M, Nakao N, Saito TR, Tanaka M: Regulation of prolactin receptor gene expression in the rat choroid plexus via transcriptional activation of multiple first exons during postnatal development and lactation. Exp Anim 2013; 62: 49-56.
30. McKee DT, Poletini MO, Bertram R, Freeman ME: Oxytocin action at the lactotroph is required for prolactin surges in cervically stimulated ovariectomized rats. Endocrinology 2007; 148: 4649-4657. (Pubitemid 47481529)
31. Sirzen-Zelenskaya A, Gonzalez-Iglesias AE, Boutet de Monvel J, Bertram R, Freeman ME, Gerber U, Egli M: Prolactin induces a hyperpolarizing current in rat paraventricular oxytocinergic neurones. J Neuroendocrinol 2011; 23: 883-893.
32. Helena CV, Cristancho-Gordo R, Gonzalez- Iglesias AE, Tabak J, Bertram R, Freeman ME: Systemic oxytocin induces a prolactin secretory rhythm via the pelvic nerve in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 2011; 301:R676-681.
33. Poletini MO, McKee DT, Szawka RE, Bertram R, Helena CV, Freeman ME: Cervical stimulation activates A1 and locus coeruleus neurons that project to the paraventricular nucleus of the hypothalamus. Brain Res Bull 2012; 88: 566-573.
34. Ben-Jonathan N, Neill MA, Arbogast LA, Peters LL, Hoefer MT: Dopamine in hypophysial portal blood: relationship to circulating prolactin in pregnant and lactating rats. Endocrinology 1980; 106: 690-696. (Pubitemid 10135095)
35. Pi XJ, Grattan DR: Increased prolactin receptor immunoreactivity in the hypothalamus of lactating rats. J Neuroendocrinol 1999; 11: 693-705. (Pubitemid 29401529)
36. Pi XJ, Grattan DR: Increased expression of both short and long forms of prolactin receptor mRNA in hypothalamic nuclei of lactating rats. J Mol Endocrinol 1999; 23: 13-22. (Pubitemid 29369555)
37. Pi X, Grattan DR: Expression of prolactin receptor mRNA is increased in the preoptic area of lactating rats. Endocrine 1999; 11: 91-98.
38. Ma FY, Grattan DR, Goffin V, Bunn SJ: Prolactin- regulated tyrosine hydroxylase activity and messenger ribonucleic acid expression in mediobasal hypothalamic cultures: the differential role of specific protein kinases. Endocrinology 2005; 146: 93-102. (Pubitemid 40051728)
39. Ma FY, Anderson GM, Gunn TD, Goffin V, Grattan DR, Bunn SJ: Prolactin specifically activates signal transducer and activator of transcription 5b in neuroendocrine dopaminergic neurons. Endocrinology 2005; 146:5112-5119. (Pubitemid 41653024)
40. Yip SH, Eguchi R, Grattan DR, Bunn SJ: Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a. J Neuroendocrinol 2012; 24: 1484-1491.
41. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA: Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998; 19: 225-268. (Pubitemid 29117815)
42. Ben-Jonathan N, LaPensee CR, LaPensee EW: What can we learn from rodents about prolactin in humans? Endocr Rev 2008; 29: 1-41. (Pubitemid 351252745)
43. Clevenger CV, Furth PA, Hankinson SE, Schuler LA: The role of prolactin in mammary carcinoma. Endocr Rev 2003; 24: 1-27. (Pubitemid 36223277)
44. Olazabal IM, Munoz JA, Rodriguez-Navas C, Alvarez L, Delgado-Baeza E, Garcia-Ruiz JP: Prolactin's role in the early stages of liver regeneration in rats. J Cell Physiol 2009; 219:626-633.
45. Huang C, Snider F, Cross JC: Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy. Endocrinology 2009; 150: 1618-1626.
46. DeVito WJ, Okulicz WC, Stone S, Avakian C: Prolactin-stimulated mitogenesis of cultured astrocytes. Endocrinology 1992; 130: 2549-2556.
47. Buckley AR: Prolactin, a lymphocyte growth and survival factor. Lupus 2001; 10: 684-690. (Pubitemid 33041660)
48. Maroulakou IG, Oemler W, Naber SP, Klebba I, Kuperwasser C, Tsichlis PN: Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. J Cell Physiol 2008; 217: 468-477.
49. Shelly S, Boaz M, Orbach H: Prolactin and autoimmunity. Autoimmun Rev 2012; 11:A465-A470.
50. Tanaka T, Shiu RP, Gout PW, Beer CT, Noble RL, Friesen HG: A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 1980; 51:1058-1063. (Pubitemid 11225461)
51. Gaytan F, Bellido C, Morales C, Sanchez-Criado JE: Luteolytic effect of prolactin is dependent on the degree of differentiation of luteal cells in the rat. Biol Reprod 2001; 65: 433-441. (Pubitemid 32702307)
52. Gaytan F, Bellido C, Morales C, Sanchez-Criado JE: Cyclic changes in the responsiveness of regressing corpora lutea to the luteolytic effects of prolactin in rats. Reproduction 2001; 122: 411-417. (Pubitemid 32834455)
53. Bowen JM, Keyes PL: Repeated exposure to prolactin is required to induce luteal regression in the hypophysectomized rat. Biol Reprod 2000; 63: 1179-1184.
54. Foitzik K, Krause K, Conrad F, Nakamura M, Funk W, Paus R: Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol 2006; 168: 748-756. (Pubitemid 43327727)
55. Seriwatanachai D, Krishnamra N, Charoenphandhu N: Chondroregulatory action of prolactin on proliferation and differentiation of mouse chondrogenic ATDC5 cells in 3-dimensional micromass cultures. Biochem Biophys Res Commun 2012; 420: 108-113.
56. Gado K, Pallinger E, Kovacs P, Takacs E, Szilvasi I, Toth BE, Nagy G, Domjan G, Falus A: Prolactin influences proliferation and apoptosis of a human IgE secreting myeloma cell line, U266. Immunol Lett 2002; 82:191-196. (Pubitemid 34556964)
57. Binart N, Bachelot A, Bouilly J: Impact of prolactin receptor isoforms on reproduction. Trends Endocrinol Metab 2010; 21: 362-368.
58. Chipoy C, Brounais B, Trichet V, Battaglia S, Berreur M, Oliver L, Juin P, Redini F, Heymann D, Blanchard F: Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53. Oncogene 2007; 26: 6653-6664. (Pubitemid 47573687)
59. Stankiewicz TR, Loucks FA, Schroeder EK, Nevalainen MT, Tyler KL, Aktories K, Bouchard RJ, Linseman DA: Signal transducer and activator of transcription-5 mediates neuronal apoptosis induced by inhibition of Rac GTPase activity. J Biol Chem 2012; 287:16835-16848.
60. Radl DB, Ferraris J, Boti V, Seilicovich A, Sarkar DK, Pisera D: Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor. PLoS One 2011; 6:e18097.
61. Radl DB, Zarate S, Jaita G, Ferraris J, Zaldivar V, Eijo G, Seilicovich A, Pisera D: Apoptosis of lactotrophs induced by D2 receptor activation is estrogen dependent. Neuroendocrinology 2008; 88: 43-52. (Pubitemid 352009118)
62. Zarate S, Jaita G, Zaldivar V, Radl DB, Eijo G, Ferraris J, Pisera D, Seilicovich A: Estrogens exert a rapid apoptotic action in anterior pituitary cells. Am J Physiol Endocrinol Metab 2009; 296:E664-671.
63. Zarate S, Zaldivar V, Jaita G, Magri L, Radl D, Pisera D, Seilicovich A: Role of estrogens in anterior pituitary gland remodeling during the estrous cycle. Front Horm Res 2010; 38:25-31.
64. Candolfi M, Jaita G, Zaldivar V, Zarate S, Pisera D, Seilicovich A: Tumor necrosis factor- alpha-induced nitric oxide restrains the apoptotic response of anterior pituitary cells. Neuroendocrinology 2004; 80: 83-91. (Pubitemid 39664077)
65. Jaita G, Candolfi M, Zaldivar V, Zarate S, Ferrari L, Pisera D, Castro MG, Seilicovich A: Estrogens up-regulate the Fas/FasL apoptotic pathway in lactotropes. Endocrinology 2005; 146: 4737-4744. (Pubitemid 41446611)
66. Haedo MR, Gerez J, Fuertes M, Giacomini D, Paez-Pereda M, Labeur M, Renner U, Stalla GK, Arzt E: Regulation of pituitary function by cytokines. Horm Res 2009; 72: 266-274.
67. Candolfi M, Zaldivar V, Jaita G, Seilicovich A: Anterior pituitary cell renewal during the estrous cycle. Front Horm Res 2006; 35: 9-21. (Pubitemid 44024238)
68. Morel G, Ouhtit A, Kelly PA: Prolactin receptor immunoreactivity in rat anterior pituitary. Neuroendocrinology 1994; 59: 78-84. (Pubitemid 24026917)
69. Nagano M, Kelly PA: Tissue distribution and regulation of rat prolactin receptor gene expression. Quantitative analysis by polymerase chain reaction. J Biol Chem 1994; 269: 13337-13345.
70. Nogami H, Hoshino R, Ogasawara K, Miyamoto S, Hisano S: Region-specific expression and hormonal regulation of the first exon variants of rat prolactin receptor mRNA in rat brain and anterior pituitary gland. J Neuroendocrinol 2007; 19: 583-593. (Pubitemid 47065104)
71. Ferraris J, Boutillon F, Bernadet M, Seilicovich A, Goffin V, Pisera D: Prolactin receptor antagonism in mouse anterior pituitary: effects on cell turnover and prolactin receptor expression. Am J Physiol Endocrinol Metab 2012; 302:E356-E364.
72. Melmed S, Carlson HE, Briggs J, Hershman JM: Autofeedback of prolactin in cultured prolactin-secreting pituitary cells. Horm Res 1980; 12: 340-344. (Pubitemid 10056527)
73. Devost D, Boutin JM: Autoregulation of the rat prolactin gene in lactotrophs. Mol Cell Endocrinol 1999; 158: 99-109.
74. Herbert DC, Ishikawa H, Rennels EG: Evidence for the autoregulation of hormone secretion by prolactin. Endocrinology 1979; 104: 97-100. (Pubitemid 9084594)
75. Swaminathan G, Varghese B, Thangavel C, Carbone CJ, Plotnikov A, Kumar KG, Jablonski EM, Clevenger CV, Goffin V, Deng L, Frank SJ, Fuchs SY: Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2. J Endocrinol 2008; 196:R1-R7. (Pubitemid 351298528)
76. Djiane J, Houdebine LM, Kelly PA: Downregulation of prolactin receptors in rabbit mammary gland: differential subcellular localization. Proc Soc Exp Biol Med 1981; 168:378-381. (Pubitemid 12134833)
77. Hosojima H, Wyche JH: Prolactin control of growth and prolactin autoregulation in cultured human pituitary cells. Horm Res 1985; 21: 240-245. (Pubitemid 15040619)
78. Krown KA, Wang YF, Ho TW, Kelly PA, Walker AM: Prolactin isoform 2 as an autocrine growth factor for GH3 cells. Endocrinology 1992; 131: 595-602.
79. Saiardi A, Bozzi Y, Baik JH, Borrelli E: Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 1997; 19: 115-126. (Pubitemid 27332998)
80. Cruz-Soto ME, Scheiber MD, Gregerson KA, Boivin GP, Horseman ND: Pituitary tumorigenesis in prolactin gene-disrupted mice. Endocrinology 2002; 143: 4429-4436. (Pubitemid 35239577)
81. Schuff KG, Hentges ST, Kelly MA, Binart N, Kelly PA, Iuvone PM, Asa SL, Low MJ: Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest 2002; 110: 973-981.
82. Yin P, Arita J: Proestrous surge of gonadotropin- releasing hormone secretion inhibits apoptosis of anterior pituitary cells in cycling female rats. Neuroendocrinology 2002; 76:272-282. (Pubitemid 35404280)
83. Hashi A, Mazawa S, Kato J, Arita J: Pentobarbital anesthesia during the proestrous afternoon blocks lactotroph proliferation occurring on estrus in female rats. Endocrinology 1995; 136: 4665-4671.
84. Flurkey K, Gee DM, Sinha YN, Wisner JR, Jr, Finch CE: Age effects on luteinizing hormone, progesterone and prolactin in proestrous and acyclic C57BL/6j mice. Biol Reprod 1982; 26: 835-846. (Pubitemid 12024255)
85. Michael SD: Plasma prolactin and progesterone during the estrous cycle in the mouse. Proc Soc Exp Biol Med 1976; 153: 254-257. (Pubitemid 8018724)
86. Jabbour HN, Kelly PA: Prolactin receptor subtypes: a possible mode of tissue specific regulation of prolactin function. Rev Reprod 1997; 2: 14-18. (Pubitemid 27165962)
87. Berlanga JJ, Garcia-Ruiz JP, Perrot-Applanat M, Kelly PA, Edery M: The short form of the prolactin (PRL) receptor silences PRL induction of the beta-casein gene promoter. Mol Endocrinol 1997; 11: 1449-1457. (Pubitemid 27366755)
88. Anderson GM, Kieser DC, Steyn FJ, Grattan DR: Hypothalamic prolactin receptor messenger ribonucleic acid levels, prolactin signaling, and hyperprolactinemic inhibition of pulsatile luteinizing hormone secretion are dependent on estradiol. Endocrinology 2008; 149: 1562-1570. (Pubitemid 351468342)
89. Bowen JM, Telleria CM, Towns R, Keyes PL: Downregulation of long-form prolactin receptor mRNA during prolactin-induced luteal regression. Eur J Endocrinol 2000; 143:285-292. (Pubitemid 30622365)
90. Shao R, Nutu M, Weijdegard B, Egecioglu E, Fernandez-Rodriguez J, Tallet E, Goffin V, Ling C, Billig H: Differences in prolactin receptor (PRLR) in mouse and human fallopian tubes: evidence for multiple regulatory mechanisms controlling PRLR isoform expression in mice. Biol Reprod 2008; 79: 748-757.
91. Moldrup A, Petersen ED, Nielsen JH: Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells. Endocrinology 1993; 133: 1165-1172. (Pubitemid 23267768)
92. Damiano JS, Rendahl KG, Karim C, Embry MG, Ghoddusi M, Holash J, Fanidi A, Abrams TJ, Abraham JA: Neutralization of prolactin receptor function by monoclonal antibody LFA102, a novel potential therapeutic for the treatment of breast cancer. Mol Cancer Ther 2013; 12: 295-305.